Strota/ Newsroom/ 2026-09-29

DRREDDY jumped +2.5% on a box breakout

Strota Newsroom · session of 2026-09-29 · market close · DRREDDY stock page →

Dr. Reddy's Laboratories Ltd. (DRREDDY) jumped +2.5% to ₹1,251.90 with 4 signals firing. Here is what the exchange data shows.

Dr. Reddy's Laboratories closed at ₹1,251.90 on Tuesday, up 2.53%, after opening 1.82% above its previous close of ₹1,221.00 and holding that gap through the session. It printed a high of ₹1,252.80 and finished within a whisker of it, so the day's gains were kept rather than given back.

The trigger visible in the headlines was a change of view from a global brokerage. CNBC TV18 reported that Citi upgraded the stock after three years and raised its target, though the record here does not carry the new figure. NDTV Profit framed the session as Dr. Reddy's outperforming peers as the pharma index bucked a weaker broader market, and HDFC Sky's midday list showed the stock leading the gainers. A headline is a report of a view, not a company disclosure, and the pack carries no filing from the company itself.

The trading footprint was decisive rather than tentative. Strota's live screens recorded a volume spike of 7.6x with the stock above its volume-weighted average price by 0.75%, a gap-and-hold session of 1.8% and a close at the day's high. Relative volume ran at 3.82 times normal.

No futures-and-options positioning is recorded for this counter, and the institutional deal file is empty, so the picture rests on price, volume and headline flow: a stock that gapped up, stayed up and closed strong on heavy volume.

Technically the move carried the stock above both its 50-day and 200-day moving averages, and the pack flags a Darvas breakout, a structure in which the price clears the top of its recent trading range. The 14-day relative strength index is 70.2, the level traders conventionally treat as the edge of overbought territory. The stock is 11.52% below its 52-week high and 13.71% above its 52-week low, with positive returns over both the past week and the past month.

The Nifty closed 0.28% lower, so the gain ran against the market. The data establishes a broker upgrade in the headlines, a gap-and-hold session and the heaviest volume in recent weeks. It does not establish what the revised view is worth, or how much of the move came from rotation into pharma defensives on a weak index day.

The numbers

Signals that fired

Technical context

Volume ran at 3.8× its 20-day average; rsi(14) sits at 70; price is 11.5% from the 52-week high; trading above the 50-dma and 200-dma.

Recent headlines

Sources

Keep digging

How this article was made: Strota assembled the exchange data above (prices, F&O open interest, bulk/block deals, SEBI PIT filings, indicator readings and public headlines) and an AI model wrote the narrative strictly from that evidence — it is not permitted to add outside facts or numbers. Every figure comes from the underlying exchange/public data.